EGAPP investigated tests for tumor expression profiling in patients with breast cancer, UGT1A1 genotyping for metastatic colorectal cancer, and genetic testing for Lynch syndrome mutation in newly diagnosed colorectal cancer patients.
The combination of technology that permits the analysis of small amounts of DNA, increased availability of testing services, and lack of regulations to protect genetic privacy create an environment ripe for surreptitious testing.
While pharmacogenomics holds great promise, significant scientific, economic, policy, and practical challenges must be faced before the field's potential can be realized.
Considering the life-altering information that paternity testing can provide, it is imperative that laboratories perform the tests accurately and reliably.
1717 Massachusetts Avenue, NW, Suite 530 Washington, DC 20036 Phone: 202.663.5971 Fax: 202.663.5992 Contact Webmaster
The Genetics and Public Policy Center at Johns Hopkins University is a trusted source of information about, and analysis of, public policy related to human genetics.
